The physiological roles of phospholipase C (PLC) ␤2 in hematopoiesis, leukocyte function, and host defense against infection were investigated using a mouse line that lacks PLC ␤2. PLC ␤2 deficiency did not affect hematopoiesis, but it blocked chemoattractant-induced Ca 2؉ release, superoxide production, and MAC-1 up-regulation in neutrophils. In view of these effects, it was surprising that the absence of PLC ␤2 enhanced chemotaxis of different leukocyte populations and sensitized the in vivo response of the PLC ␤2-deficient mice to bacteria, viruses, and immune complexes. These data raise questions about the roles that PLC ␤2 may play in signal transduction induced by chemoattractants in leukocytes.
Phospholipase C (PLC) hydrolyzes phosphatidylinositol 4,5-bisphosphate to produce two important second messengers, inositol trisphosphates and diacylglycerol (1) . There are four different PLC ␤ isoforms that have been cloned. They are all regulated by heterotrimeric G proteins, and there is evidence suggesting that different isoforms may be involved in a variety of signaling circuits. The ␤2 isoform is found primarily in hematopoietic cells (2, 3) , and it can be activated by both the G␣ subunits of the Gq class and by the ␤␥ subunits generated by a number of different heterotrimeric G proteins (3) (4) (5) (6) (7) (8) (9) . Cotransfection experiments in COS-7 and HEK cells suggest that PLC ␤2 may function downstream of chemoattractant receptors. Transfection of receptors for complement component C5a and fMet-Leu-Phe (fMLP) (10) , interleukin (IL)-8 receptors a and b (11) , and CKR-1 and -2 (12) demonstrated that each of the receptors activates PLC ␤2 through the pertussis toxin (PTx)-sensitive release of ␤␥ from the G i class of heterotrimeric G proteins. In addition, this may be a primary signaling pathway in neutrophils, because much of the PLC activity elicited through chemoattractant receptors also appears to function through the G i -mediated release of ␤␥ (13) (14) (15) (16) (17) .
To confirm the existence of the G␤␥-PLC ␤2 pathway in vivo and to investigate the function of the pathway in hematopoiesis and leukocyte function, we generated a mouse line that lacks PLC ␤2. We found that PLC ␤2 is the major isoform that mediates PTx-sensitive PLC activation induced by chemoattractants and that PLC ␤2 is critical to many chemoattractant-elicited responses, including Ca 2ϩ efflux, superoxide production, and up-regulation of MAC-1. However, PLC ␤2 deficiency does not attenuate chemoattractant-induced chemotaxis; surprisingly, it was found to enhance the process.
MATERIALS AND METHODS

Generation of PLC ␤2-Null
Mice. An 8-kb genomic DNA from a 129SV agouti mouse strain library contains two exons of the PLC ␤2 gene, and it was used to make the gene-targeting construct. The exons encoded residues 378-464, which are located in the C terminus of the X box. Parts of the exons were replaced with a neomycin-resistance gene. The gene-targeting construct was transfected into embryonic stem (ES) cells (CJ7 clone) by electroporation. After selection with Geneticin, eight ES clones were obtained in which one of the PLC ␤2 genes was disrupted. Two of the ES cell clones were microinjected into blastocysts, and eight chimeras were generated with chimerism ranging from 40% to 95%. These chimeras were then backcrossed with 129SV to generate inbred heterozygotes. Finally, interbreeding of heterozygous siblings yielded animals homozygous for the desired mutation-i.e., mice lacking PLC ␤2. The animals are maintained under specific pathogen-free conditions. PLC Assays. Neutrophils used for PLC assays were isolated from mouse bone marrow by using a neutrophil isolation kit from Cardinal Associates (Santa Fe, NM). Cells were labeled overnight with [ 3 H]inositol at 5 Ci͞ml (1 Ci ϭ 37 kBq), and the levels of inositol phosphates were determined as previously described (18) . Ca 2؉ Eff lux, Superoxide Production, and Surface MAC-1 Expression Assays. Mice (8-10 weeks old) were injected intraperitoneally with 2 ml of 2% casein (19) . After 3 hr the peritoneal cavities were lavaged with Hanks' balanced salt solution (HBSS), and the peritoneal exudate cells (PEC) were collected by low-speed centrifugation. The percentage of neutrophils was determined by cytospin differential count; typically the recovered cells were Ͼ90% neutrophils. The cells were spun down and resuspended in HBSS and were ready for the assays. In the Ca 2ϩ assays, PEC were loaded with Fura-2͞AM (1 M) in HBSS at 37°C for 30 min and washed twice with HBSS. The cells were resuspended in HBSS, and the 340͞380-nm excitation ratio (emission ϭ 510 nm) of the cells in the absence and presence of ligand was determined with a fluorometer as directed by the user manual (Quantamaster, Photon Technology International, Princeton, NJ). The intracellular [Ca 2ϩ ] was calculated on the basis of a calibration scale generated by using Fura-2 free acid (20) .
The levels of superoxide anion in neutrophils were determined as previously described (21) . Briefly, PEC were primed with or without 0.2 g͞ml lipopolysaccharide (LPS) at 37°C for 15 min. A cocktail of p-hydroxyphenylacetate (10 mg͞ml), superoxide dismutase (1 mg͞ml), and horseradish peroxidase (8 mg͞ml) was made up in a volume ratio of 25:40:10, and 20 l was used per 100 l of cell suspension. Cells were incubated with the cocktail in either the absence or the presence of chemoattractant fMLP (1 M) at 37°C for 60 min. The cells were excited at 323 nm, and the emission at 400 nm was
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Surface expression of MAC-1 on neutrophils was assessed by incubating cells with 1 M fMLP for 5 min at 37°C and then incubating with fluorescein isothiocyanate-conjugated rat anti-MAC-1 antibody or rat isotype-matched control antibody on ice for 30 min. MAC-1-positive cells were identified in a gated population based on forward and side scatter profiles. Flow cytometry was performed using an Elite Flowcytometer (Coulter). Data were acquired with 10,000 cells per sample and expressed as the percentage of maximal mean channel fluorescence minus that obtained with the control antibody.
Chemotaxis Assay. Bone marrow cells were freed of red blood cells by hypotonic lysis, and the CD3 ϩ T cells were isolated from spleen by negative selection using the mouse T cell enrichment kit from R & D Systems. The cells were resuspended at a concentration of 10 7 cells per ml in HBSS, and chemotaxis in response to various ligands was determined by loading individual chambers of a 48-well chemotaxis apparatus (Nuclepore) with 50 l of cells. The chamber was incubated at 37°C for 1 hr. Migrating cells adhering to the bottom of the membrane separating the chambers were stained with Diff-Quick (Fisher) and counted under 400ϫ magnification. The cells in five random fields were counted, noting the differential percentages of mononuclear cells, neutrophils, and eosinophils.
RESULTS
The PLC ␤2 gene was disrupted as shown in Fig. 1A . The X and Y boxes represent conserved amino acid sequence motifs found in all members of the PLC family, and they comprise the catalytic domain responsible for PLC activity (22) . The exon of the PLC ␤2 gene, which encodes part of the X box, was disrupted by the insertion of a neomycin-resistance geneexpression unit. Homologous recombinants that maintained the null mutation in the PLC ␤2 gene were detected by PCR with the primers shown in Fig. 1 A, and the genomic structure was confirmed by Southern analysis (data not shown). No PLC ␤2 protein was detected with a PLC ␤2-specific antiserum in homogenates from homozygous PLC ␤2-deficient mice (Fig.  1B) .
The homozygous deficient mice show no apparent phenotypes at the systemic and cellular levels; PLC ␤2-deficient mice are similar to wild-type littermates in body weight, survival rate, appearance, and behavior. Flow cytometric analyses did not reveal any significant changes in populations of CD3 ϩ , CD4 ϩ , CD8
ϩ , IgM ϩ , CD45 ϩ , Gr-1, MAC-1 ϩ , and Mac-3 ϩ cells derived from spleen, thymus, and bone marrow. Differential leukocyte counts of cells with morphologies corresponding to mononuclear cells, eosinophils, and neutrophils in bone marrow, peripheral blood, and peritoneal cavity lavage were similar in PLC ␤2-deficient and wild-type mice. Therefore, PLC ␤2 does not appear to be required for production of leukocytes.
To understand the involvement of PLC ␤2 in chemoattractant-induced responses, we investigated how the deficiency affects inositol phosphate accumulation, superoxide production, elevation of intracellular Ca 2ϩ , and chemotaxis in response to chemoattractants. The fMLP-induced accumulation of inositol phosphates in neutrophils isolated from the bone marrow of PLC ␤2-null and wild-type mice was determined. As shown in Table 1 , fMLP induced significant increases in the levels of inositol phosphates in neutrophils from wild-type mice, and the response was sensitive to PTx. However, fMLPinduced accumulation of inositol phosphates was significantly reduced in neutrophils isolated from the PLC ␤2-null mice, although the levels of inositol phosphates remained at 20% of ϩ͞ϩ levels. Given the absence of PLC ␤2 protein (Fig. 1B) , the residual activity is likely the result of other PLC ␤ isoforms and͞or PLC ␥ isoforms that are regulated by fMLP. In any event, it is clear that PLC ␤2 is the major isoform that mediates the PTx-sensitive accumulation of inositol phosphates induced by fMLP.
fMLP-mediated Ca 2ϩ release, superoxide production, and up-regulation of MAC-1 expression in neutrophils were also investigated. In neutrophils lacking PLC ␤2, there was only about a 30% increase in fMLP-induced intracellular Ca 2ϩ compared with neutrophils derived from wild-type mice (Table 1). Similar results were also observed with IL-8-and MIP-1␣-induced activation (data not shown). We also found that fMLP (Table 1) , IL-8, and MIP-1␣ (data not shown)-induced superoxide production and up-regulation of cell surface expression of MAC-1 were significantly attenuated in neutrophils lacking PLC ␤2 (Table 1) . In contrast, lipopolysaccharide-induced superoxide production was not affected in neutrophils lacking PLC ␤2 (data not shown). Thus, the mechanism for the induced response is intact, but coupling to the chemoattractant receptors is lost in these cells. We conclude that PLC ␤2 plays a central role in specific chemoattractant-induced superoxide production and up-regulation of MAC-1 as well as in chemoattractant-induced Ca 2ϩ release and inositol trisphosphate formation in neutrophils.
One of the major biological responses mediated by chemoattractants is chemotaxis of leukocytes along a gradient of attractant (23) . fMLP-and IL-8-induced chemotaxis activities were assessed using leukocytes isolated from bone marrow of PLC ␤2-null and wild-type mice in Boyden chamber assays. Both ligands attracted only neutrophils as judged on the basis of the morphology of the migrating cells bound to the membrane after differential staining. It is clear that IL-8-and fMLP-induced chemotaxis of PLC ␤2-deficient neutrophils was not impaired (Fig. 2 A and B) . On the contrary, neutrophils derived from the PLC ␤2-null mice were consistently found to be slightly more sensitive to lower concentrations of fMLP and IL-8 in the chemotaxis assays (Fig. 2 A and B) . MIP-1␣-induced chemotaxis of bone marrow leukocytes was also investigated. MIP-1␣ attracted both mouse polymorphonu- clear and mononuclear cells. Once again, cells lacking PLC ␤2 were more effectively recruited by MIP-1␣-induced chemotaxis than those containing PLC ␤2 (Fig. 2C) . In particular, MIP-1␣-induced chemotaxis of mouse eosinophils was greatly enhanced in the absence of PLC ␤2 (Fig. 2C) . The mononuclear cells attracted by MIP-1␣ included both monocytes and lymphocytes. To investigate the chemotaxis of lymphocytes, we isolated CD3 ϩ T cells from spleen. We tested both MIP-1␣ and RANTES as chemoattractants that are known for their ability to induce activity in T lymphocytes (13) (14) (15) . Both ligands induced stronger chemotaxis activity in cells lacking PLC ␤2 (Fig. 2 D and E) . The study was also extended to eotaxin-induced chemotaxis of eosinophils. Eotaxin, like the other chemoattractants, elicited stronger chemotaxis activity from eosinophils that lacked PLC ␤2 than from wild-type cells (Fig. 2F) . In summary, deficiency in the PLC ␤2-linked pathway does not decrease the chemotaxis response as measured by the Boyden chamber assay; instead the loss of the PLC ␤2 pathway augments chemotaxis. The observations of enhanced chemotaxis were confirmed using an in vivo model of leukocyte recruitment. Mice were sensitized with two subcutaneous injections of methylated bovine serum albumin (MBSA) or saline solution over a 2-week period, followed 1 week later by an intrathoracic injection of MBSA. The day following this challenge the thoracic cavity was flushed with sterile saline containing heparin. The total number of nucleated cells and the fraction of eosinophils in the thoracic cavity of the MBSA-immunized mutant and wild-type mice were compared. Approximately 4 times as many eosinophils (5.4 Ϯ 1.2 ϫ 10 5 ) were recruited in the PLC ␤2-null mice (n ϭ 7) as in the wild-type animals (1.5 Ϯ 0.4 ϫ 10 5 , n ϭ 5). These data are consistent with the in vitro results and demonstrate that eosinophils derived from PLC ␤2-null mice have enhanced chemotactic responses.
The potential systemic effects of the PLC ␤2 deficiency were assessed by using two models of infection. Bacterial infection was achieved by injecting mice with ampicillin-resistant bacteria. The resulting peritonitis was assessed the following day as a function of the number of surviving bacteria recovered from a peritoneal cavity lavage. The number of bacteria that survived in PLC ␤2-null mice was less than in the wild-type mice (Fig. 3A) . This result suggests that the PLC ␤2 deficiency does not compromise the host's ability to deal with the bacterial challenge. The mice were also challenged with Friend leukemia virus (FLV), which induces splenomegaly (24) . FLV was injected peritoneally, and 2 weeks later the spleens were weighed. The weights of wild-type spleens infected with FLV were double those of noninfected, but FLV induced only slight increases in spleen weight in the PLC ␤2-null mice (Fig. 3B ). There is a clear statistical difference between the weight of the PLC ␤2-null spleens and those of wild type after treatment with FLV. This difference together with the difference in the bacterial survival rate suggests that disruption of the PLC ␤2-linked pathway does not impair, and may even enhance, the in vivo response to bacterial and viral exposure.
DISCUSSION
Our data delineate two apparently different functions for PLC ␤2 in responses mediated by chemoattractant receptors. PLC ␤2 deficiency results in a significant reduction of chemoattractant-induced inositol phosphate accumulation, intracellular Ca 2ϩ levels, superoxide production, and cell surface MAC-1 expression. However, leukocytes lacking PLC ␤2 showed enhanced chemoattractant-induced chemotaxis. These results suggest that specific immediate molecular responses to chemoattractants are mediated through PLC ␤2 signaling, but more complex responses such as chemotaxis are regulated by inputs from a number of pathways. Our data suggest that PLC ␤2 may be part of a negative pathway that attenuates chemotaxis. Previous reports (25) (26) (27) (28) (29) have implicated protein kinase C (PKC) in desensitization of G proteinmediated signal transduction, including responses to fMLP, IL-8, and platelet-activating factor. PLC ␤2 may be a required component of this desensitization pathway. In addition, the role of PLC ␤2 is cell-specific, since PLC ␤2-null leukocyte populations differentially responded to chemoattractants (Fig.  2) . Our results also suggest that PLC ␤2-mediated superoxide production and up-regulation of MAC-1 in neutrophils may not be essential for the host's response to bacterial challenges.
We do not know if the enhanced chemotaxis observed in the leukocytes is the cause of the apparent increase in resistance to viral challenge. Nevertheless, it is clear that PLC ␤2 plays a role in leukocyte functions at the cellular and at the whole animal level. The PLC ␤2 mice provide a means to analyze the contributions of various signal transduction pathways to complex cellular and tissue functions in vivo.
